First Trust Advisors LP Bellerophon Therapeutics, Inc. Transaction History

First Trust Advisors LP

  • $95 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$3.75 - $4.86 $76,931 - $99,702
-20,515 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$3.83 - $5.65 $2,769 - $4,084
-723 Reduced 3.4%
20,515 $99,000
Q1 2021

May 14, 2021
BUY
$5.07 - $8.27 $8,649 - $14,108
1,706 Added 8.73%
21,238 $110,000
Q4 2020

Feb 02, 2021
SELL
$6.12 - $10.37 $5,403 - $9,156
-883 Reduced 4.33%
19,532 $130,000
Q3 2020

Nov 05, 2020
BUY
$9.27 - $13.79 $189,247 - $281,522
20,415 New
20,415 $208,000

Others Institutions Holding BLPH

# of Institutions
1
Shares Held
44K
Call Options Held
0
Put Options Held
0
View Full List

About Bellerophon Therapeutics, Inc.

BLPH Quotes by TradingView
  • Ticker BLPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,545,450
  • Market Cap $382K
  • Description
  • Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...
More about BLPH
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email